Skip to contentS
Surgery Partners, Inc.
S
SGRYSurgery Partners, Inc. Q2 2023 · 10-Q
Revenue$667.60M$667.60M+8.5% vs Q2 2022 Net Income$18.90M$18.90MN/M vs Q2 2022 EPS Diluted$0.15$0.15N/M vs Q2 2022 Operating Income$97,600,000+27.6% Operating Cash Flow
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Surgery Partners, Inc. · CIK 1638833 · Engraved from SEC EDGAR
derived
Free Cash Flowderived$26,300,000+33.5% Margins · derivedOperating margin14.6%+2.2 pt vs Q2 2022
Net margin2.8%+5.8 pt vs Q2 2022
ended Jun 30, 2023 · filed Aug 1, 2023 · 32 d after period end